Areej Abuhammad

6PUBLICATIONS
18CO-AUTHORS
Biologically active moleculesMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Toxicology (incl. clinical toxicology)Genetically modified horticulture plants
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 04, 2026
Arbutus andrachne Extracts Exhibit In Vitro Neuraminidase (N9) Inhibitory Activity: A Potential Herbal Strategy Against Avian Influenza.

|May 04, 2026
Fragment-Derived Nicotinic Acid Analogues Inhibit hCA III and Downregulate CA3 Expression in HepG2 Cells.

|Oct 16, 2025
Coenzyme Q10 Ameliorates Chemotherapy-Induced Neurotoxicity in iPSC-Derived Neurons by Reducing Oxidative Stress.

Nidaa A Ababneh, Razan AlDiqs, Mohammad H Gharandouq

|Feb 10, 2023
Structural and biochemical analysis of human inositol monophosphatase-1 inhibition by ebselen.

Areej Abuhammad, Nicola Laurieri, Alistair Rice

|Sep 30, 2022
Fusarium verticillioides NAT1 (FDB2) N-malonyltransferase is structurally, functionally and phylogenetically distinct from its N-acetyltransferase (NAT) homologues.

Eleni-Pavlina Karagianni, Evanthia Kontomina, Edward D Lowe

|Jun 14, 2017
Computational modeling of the bat HKU4 coronavirus 3CLpro inhibitors as a tool for the development of antivirals against the emerging Middle East respiratory syndrome (MERS) coronavirus.

Areej Abuhammad, Rua'a A Al-Aqtash, Brandon J Anson

Pageof 1

Frequent Collaborators

2 joint publications

Mutasem O Taha

1 joint publications

Edward D Lowe

1 joint publications

Giannoulis Fakis

1 joint publications

Anthony E Glenn